These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

466 related items for PubMed ID: 9825572

  • 1. Expression of cell cycle regulatory genes in chronic myelogenous leukemia.
    Iolascon A, Della Ragione F, Giordani L, Serra A, Saglio G, Faienza MF.
    Haematologica; 1998 Sep; 83(9):771-7. PubMed ID: 9825572
    [Abstract] [Full Text] [Related]

  • 2. Comparison of the effectiveness of adenovirus vectors expressing cyclin kinase inhibitors p16INK4A, p18INK4C, p19INK4D, p21(WAF1/CIP1) and p27KIP1 in inducing cell cycle arrest, apoptosis and inhibition of tumorigenicity.
    Schreiber M, Muller WJ, Singh G, Graham FL.
    Oncogene; 1999 Mar 04; 18(9):1663-76. PubMed ID: 10208428
    [Abstract] [Full Text] [Related]

  • 3. P53, p15INK4B, p16INK4A and p57KIP2 mutations during the progression of chronic myeloid leukemia.
    Güran S, Bahçe M, Beyan C, Korkmaz K, Yalçin A.
    Haematologia (Budap); 1998 Mar 04; 29(3):181-93. PubMed ID: 10069444
    [Abstract] [Full Text] [Related]

  • 4. Coincidental alterations of p16INK4A/CDKN2 and other genes in human lung cancer cell lines.
    Fujishita T, Mizushima Y, Kashii T, Kobayashi M.
    Anticancer Res; 1998 Mar 04; 18(3A):1537-42. PubMed ID: 9673367
    [Abstract] [Full Text] [Related]

  • 5. Differential expressions of cyclin-dependent kinase inhibitors (p27 and p21) and their relation to p53 and Ki-67 in oral squamous tumorigenesis.
    Choi HR, Tucker SA, Huang Z, Gillenwater AM, Luna MA, Batsakis JG, El-Naggar AK.
    Int J Oncol; 2003 Feb 04; 22(2):409-14. PubMed ID: 12527941
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Lack of mutation in the cyclin-dependent kinase inhibitor, p19INK4d, in tumor-derived cell lines and primary tumors.
    Zariwala M, Xiong Y.
    Oncogene; 1996 Nov 07; 13(9):2033-8. PubMed ID: 8934552
    [Abstract] [Full Text] [Related]

  • 8. Cell cycle regulators in bladder cancer: a multivariate survival study with emphasis on p27Kip1.
    Korkolopoulou P, Christodoulou P, Konstantinidou AE, Thomas-Tsagli E, Kapralos P, Davaris P.
    Hum Pathol; 2000 Jun 07; 31(6):751-60. PubMed ID: 10872671
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Restoration of growth arrest by p16INK4, p21WAF1, pRB, and p53 is dependent on the integrity of the endogenous cell-cycle control pathways in human glioblastoma cell lines.
    Costanzi-Strauss E, Strauss BE, Naviaux RK, Haas M.
    Exp Cell Res; 1998 Jan 10; 238(1):51-62. PubMed ID: 9457056
    [Abstract] [Full Text] [Related]

  • 11. Expression of p15(INK4B) in hematopoietic progenitors.
    Teofili L, Larocca LM, Leone G.
    Haematologica; 1999 Jan 10; 84(E-letters):E01. PubMed ID: 11084659
    [No Abstract] [Full Text] [Related]

  • 12. Tamoxifen induces p21WAF1 and p27KIP1 expression in estrogen receptor-negative lung cancer cells.
    Lee TH, Chuang LY, Hung WC.
    Oncogene; 1999 Jul 22; 18(29):4269-74. PubMed ID: 10435640
    [Abstract] [Full Text] [Related]

  • 13. Lack of imprinting of three human cyclin-dependent kinase inhibitor genes.
    Cost GJ, Thompson JS, Reichard BA, Lee JY, Feinberg AP.
    Cancer Res; 1997 Mar 01; 57(5):926-9. PubMed ID: 9041196
    [Abstract] [Full Text] [Related]

  • 14. Role of tumor suppressor genes in the development of adult T cell leukemia/lymphoma (ATLL).
    Hatta Y, Koeffler HP.
    Leukemia; 2002 Jun 01; 16(6):1069-85. PubMed ID: 12040438
    [Abstract] [Full Text] [Related]

  • 15. Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas.
    Elisei R, Shiohara M, Koeffler HP, Fagin JA.
    Cancer; 1998 Nov 15; 83(10):2185-93. PubMed ID: 9827724
    [Abstract] [Full Text] [Related]

  • 16. The cyclin-dependent kinase inhibitor (CDKI) flavopiridol disrupts phorbol 12-myristate 13-acetate-induced differentiation and CDKI expression while enhancing apoptosis in human myeloid leukemia cells.
    Cartee L, Wang Z, Decker RH, Chellappan SP, Fusaro G, Hirsch KG, Sankala HM, Dent P, Grant S.
    Cancer Res; 2001 Mar 15; 61(6):2583-91. PubMed ID: 11289135
    [Abstract] [Full Text] [Related]

  • 17. Chronic myelogenous leukemia molecular signature.
    Nowicki MO, Pawlowski P, Fischer T, Hess G, Pawlowski T, Skorski T.
    Oncogene; 2003 Jun 19; 22(25):3952-63. PubMed ID: 12813469
    [Abstract] [Full Text] [Related]

  • 18. Down-regulation of the INK4 family of cyclin-dependent kinase inhibitors by tax protein of HTLV-1 through two distinct mechanisms.
    Suzuki T, Narita T, Uchida-Toita M, Yoshida M.
    Virology; 1999 Jul 05; 259(2):384-91. PubMed ID: 10388662
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. P16Ink4a tumor suppressor function in lung cancer cells involves cyclin-dependent kinase 2 inhibition by Cip/Kip protein redistribution.
    Grimison B, Langan TA, Sclafani RA.
    Cell Growth Differ; 2000 Oct 05; 11(10):507-15. PubMed ID: 11063124
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.